Acclarent, a Johnson & Johnson subsidiary, is applying precision sensor technology to ear, nose and throat (ENT) surgery to improve outcomes and reduce the need for repeat procedures.
The US Food and Drug Administration recently cleared Acclarent’s TruDi electromagnetically navigated shaver blade to be used with
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?